Compulsory licensing for medicinal products and medical devices in the case of a national health emergency introduced in Italy

Written By

The Italian IP Code has recently been amended to impose a compulsory licensing for patents related to certain medicinal products or medical devices in the event a national health emergency is declared.

Previous rules on compulsory licencing

Articles 70 – 74 of the Italian IP Code previously provided for a compulsory licensing scheme in Italy but only in the event of:

  • a failure to work or the insufficient working of a medicinal product or medical device; or
  • a ‘dependent invention’, such as in a scenario where a patentee cannot exploit its invention without infringing a prior patent.

Compulsory licences have rarely been granted in the past in Italy.

New rules on compulsory licence for medicinal products and medical devices

Law Decree 31 May 2021 no. 77 (which was converted into law on 29 July 2021 no. 108)…

Full article available on PatentHub

Latest insights

More Insights
Curiosity line blue background

China Cybersecurity and Data Protection: Monthly Update - April 2024 Issue

Apr 26 2024

Read More
Curiosity line pink background

Bring out the wine and cheese: Enhanced protection for European GIs in New Zealand

Apr 26 2024

Read More
Green paper windmill

Green Gold: Navigating Mandatory Climate Disclosure and ESG Strategies

Apr 26 2024

Read More